Swedish Society for Medical Research

AHSCT shows long-term benefit in Swedish cohort

A large observational study has found that adults with ADHD had an elevated risk of a range of cardiovascular diseases. Researchers from the Karolinska Institute and Örebro University in Sweden found that adults with attention-deficit/hyperactivity disorder (ADHD) are more likely than those without

73% of patients with relapsing remitting multiple sclerosis were disease free 5 years after aHSCT treatment, and more than half reported improved disability.

Meta-analysis shows ICIs also improved pCR rates in HR-positive/HER2-negative disease

Adults with ADHD are at greater risk of developing a range of cardiovascular diseases than those without the condition, according to a large observational study led by researchers at Karolinska Institutet and Örebro University in Sweden. The researchers say the findings, published in the journal World Psychiatry, underscore the need to monitor cardiovascular health in people with ADHD.

A B-cell count of at least 40/µL is necessary to mount an adequate antibody response to COVID-19 boosters in patients with multiple sclerosis, new research shows.

A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.

The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however, that it breaks down rapidly in the cell. Researchers have now found an unusual way of stabilizing the protein and making it more potent. By adding a spider silk protein to p53, they show that it is possible to create a protein that is more stable and capable of killing cancer cells.